Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Voyager Therapeutics, Inc. (VYGR) had Receiveable Turnover of 3.31 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$13.37M |
|
$-27.89M |
|
-- |
|
$13.37M |
|
$43.96M |
|
$-30.59M |
|
$2.79M |
|
$-27.81M |
|
$-27.81M |
|
$-27.89M |
|
$-27.89M |
|
$-27.89M |
|
$-27.89M |
|
$-30.59M |
|
$-30.32M |
|
58.80M |
|
58.80M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$219.59M |
|
$13.29M |
|
$68.73M |
|
$288.31M |
|
$35.49M |
|
-- |
|
$32.99M |
|
$68.49M |
|
$219.83M |
|
$219.82M |
|
$219.82M |
|
55.48M |
|
| Cash Flow Statement Financials | |
$-102.20M |
|
$78.02M |
|
$0.68M |
|
$74.24M |
|
$50.74M |
|
$-23.50M |
|
$11.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-228.91% |
|
-228.91% |
|
-- |
|
-208.07% |
|
-208.69% |
|
$-104.17M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
3.31 |
27.19 |
|
-12.69% |
|
-12.69% |
|
-9.67% |
|
-12.69% |
|
$3.96 |
|
$-1.77 |
|
$-1.74 |
|